Shire Pharmaceuticals Group PLC - Shire Files Legal Suit against Barr and Impax.

PR Newswire UK Disclose, October, 2005

 
ADDERALL XRA' - Shire Files Legal Suit against Barr Laboratories and Impax 
Laboratories for Infringement of U.S. Patent No. 6,913,768 
 
Basingstoke, UK and Philadelphia, US - October 20, 2005 - Shire Pharmaceuticals 
Group plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announces that its subsidiary 
Shire Laboratories Inc. has filed a lawsuit in the U.S. District Court of the 
Southern District of New York against Barr Laboratories, Inc. ("Barr") and 
Impax Laboratories, Inc. ("Impax") for infringement of Shire Laboratories U.S. 
Patent No. 6,913,768 ("`768 Patent"). 
 
The lawsuit results from ANDAs (Abbreviated New Drug Applications) filed by 
Barr and Impax seeking FDA approval to market and sell generic versions of 
Shire's 5 mg, 10 mg, 15 mg, 20 mg, 25 mg and 30 mg ADDERALL XRA'...

            
        
    
    	    
                
                
	

		

					 
            Read the rest of this article with a Free Trial at HighBeam Research.
        				
 

    		            
	
                Premium Content Partnership | 
                	HighBeam Research provides an in-depth online archive library of reference works.